Top

Clinical Orthopaedics and Related Research®

Published in:

01-10-2013 | Symposium: 2012 Musculoskeletal Infection Society

Clostridium difficile Colitis in Patients Undergoing Lower-extremity Arthroplasty: Rare Infection With Major Impact

Authors: Mitchell Gil Maltenfort, PhD, Mohammad R. Rasouli, MD, Todd A. Morrison, BS, Javad Parvizi, MD, FRCS

Published in: Clinical Orthopaedics and Related Research® | Issue 10/2013

Abstract

Background

The prevalence of Clostridium difficile colitis is reportedly increasing in surgical patients and can negatively impact their outcome. However, as yet there are no clear estimates of the C difficile infection colitis rate and its consequences among patients undergoing total joint arthroplasty (TJA).

Questions/purposes

We asked: (1) What is the rate of C difficile colitis in TJA patients? (2) What are the risk factors of C difficile colitis in these patients? And (3) what is the effect of C difficile colitis on length of stay, in-hospital mortality, and estimated total charges?

Methods

Using ICD-9-CM diagnosis and procedure codes, we queried the Nationwide Inpatient Sample database for patients undergoing TJA for the years 2002 to 2010. Demographic data, comorbidities, occurrence of C difficile colitis, length of hospital stay, mortality, and hospital charges were extracted. Logistic regression was performed to identify predictors of C difficile colitis and its impact on in-hospital mortality.

Results

The incidence of C difficile remained less than 0.6% during the study period. Revision TJAs (odds ratio = 6.9 and 4.4 for hip and knee, respectively) and number of comorbidities (odds ratio = 1.5) increased risk of C difficile colitis. C difficile increased length of hospital stay by a week, hospital charges by USD 40,000, and in-hospital mortality to 4.66% from 0.24%.

Conclusions

Using lower and fewer doses of antibiotics in revision TJAs and among patients with many comorbidities may diminish risk of C difficile colitis and its consequent mortality.

Level of Evidence

Level II, prognostic study. See Instructions for Authors for a complete description of levels of evidence.

Agency for Healthcare Research and Quality. Healthcare Cost & Utilization Project: database and related tools from HCUP. Available at: http://www.hcup-us.ahrq.gov/toolssoftware/comorbidity/Table2-FY12-V3_7.pdf. Accessed February 18, 2013.

Al-Obaydi W, Smith CD, Foguet P. Changing prophylactic antibiotic protocol for reducing Clostridium difficile-associated diarrhoeal infections. J Orthop Surg (Hong Kong). 2010;18:320–323.PubMed

Badger VO, Ledeboer NA, Graham MB, Edmiston CE Jr. Clostridium difficile: epidemiology, pathogenesis, management, and prevention of a recalcitrant healthcare-associated pathogen. JPEN J Parenter Enteral Nutr. 2012;36:645–662.PubMedCrossRef

Bobo LD, Dubberke ER, Kollef M. Clostridium difficile in the ICU: the struggle continues. Chest. 2011;140:1643–1653.PubMedCrossRef

Bottle A, Aylin P. Comorbidity scores for administrative data benefited from adaptation to local coding and diagnostic practices. J Clin Epidemiol. 2011;64:1426–1433.PubMedCrossRef

Bureau of Labor Statistics. CPI inflation calculator. Available at: http://data.bls.gov/cgi-bin/cpicalc.pl. Accessed February 27, 2013.

Carignan A, Allard C, Pépin J, Cossette B, Nault V, Valiquette L. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis. 2008;46:1838–1843.PubMedCrossRef

Carr AJ, Robertsson O, Graves S, Price AJ, Arden NK, Judge A, Beard DJ. Knee replacement. Lancet. 2012;379:1331–1340.PubMedCrossRef

Chu YT, Ng YY, Wu SC. Comparison of different comorbidity measures for use with administrative data in predicting short- and long-term mortality. BMC Health Serv Res. 2010;10:140.PubMedCrossRef

10.

Clarke HJ, Jinnah RH, Byank RP, Cox QG. Clostridium difficile infection in orthopaedic patients. J Bone Joint Surg Am. 1990;72:1056–1059.PubMed

11.

Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208:96–103.PubMedCrossRef

12.

Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36:8–27.PubMedCrossRef

13.

Forster AJ, Taljaard M, Oake N, Wilson K, Roth V, van Walraven C. The effect of hospital-acquired infection with Clostridium difficile on length of stay in hospital. CMAJ. 2012;184:37–42.PubMed

14.

Jawa RS, Mercer DW. Clostridium difficile-associated infection: a disease of varying severity. Am J Surg. 2012;204:836–842.PubMedCrossRef

15.

Jenkins PJ, Teoh K, Simpson PM, Dave J, Simpson AH, Breusch S. Clostridium difficile in patients undergoing primary hip and knee replacement. J Bone Joint Surg Br. 2010;92:994–998.PubMedCrossRef

16.

Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. Clostridium difficile colitis: an increasing hospital-acquired illness. Am J Surg. 1995;169:480–483.PubMedCrossRef

17.

Kaplan GG, Hubbard J, Panaccione R, Shaheen AA, Quan H, Nguyen GC, Dixon E, Ghosh S, Myers RP. Risk of comorbidities on postoperative outcomes in patients with inflammatory bowel disease. Arch Surg. 2011;146:959–964.PubMedCrossRef

18.

Kirksey M, Chiu YL, Ma Y, Della Valle AG, Poultsides L, Gerner P, Memtsoudis SG. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998–2008. Anesth Analg. 2012;115:321–327.PubMedCrossRef

19.

Kurd MF, Pulido L, Joshi A, Purtill JJ, Parvizi J. Clostridium difficile infection after total joint arthroplasty: who is at risk? J Arthroplasty. 2008;23:839–842.PubMedCrossRef

20.

Kurtz S, Ong K, Lau E, Mowat F, Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89:780–785.PubMedCrossRef

21.

Kyne L, Warny M, Qamar A, Kelly CP. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med. 2000;342:390–397.PubMedCrossRef

22.

Lix LM, Quail J, Teare G, Acan B. Performance of comorbidity measures for predicting outcomes in population-based osteoporosis cohorts. Osteoporos Int. 2011;22:2633–2643.PubMedCrossRef

23.

McFarland LV, Mulligan ME, Kwok RY, Stamm WE. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med. 1989;320:204–210.PubMedCrossRef

24.

Morris AM, Jobe BA, Stoney M, Sheppard BC, Deveney CW, Deveney KE. Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? Arch Surg. 2002;137:1096–1100.PubMedCrossRef

25.

Pivec R, Johnson AJ, Mears SC, Mont MA. Hip arthroplasty. Lancet. 2012;380:1768–1777.PubMedCrossRef

26.

Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch Surg. 2007;142:624–631.PubMedCrossRef

27.

Sharabiani MT, Aylin P, Bottle A. Systematic review of comorbidity indices for administrative data. Med Care. 2012;50:1109–1118.PubMedCrossRef

28.

Sharma P, Bomireddy R, Phillips S. Clostridium difficile-associated diarrhoea after internal fixation of intertrochanteric femoral fractures. Eur J Clin Microbiol Infect Dis. 2003;22:615–618.PubMedCrossRef

29.

Shen Y, Silverstein JC, Roth S. In-hospital complications and mortality after elective spinal fusion surgery in the United States: a study of the nationwide inpatient sample from 2001 to 2005. J Neurosurg Anesthesiol. 2009;21:21–30.PubMedCrossRef

30.

Slobogean GP, Kennedy SA, Davidson D, O’Brien PJ. Single- versus multiple-dose antibiotic prophylaxis in the surgical treatment of closed fractures: a meta-analysis. J Orthop Trauma. 2008;22:264–269.PubMedCrossRef

31.

Stewart DB, Hollenbeak CS. Clostridium difficile colitis: factors associated with outcome and assessment of mortality at a national level. J Gastrointest Surg. 2011;15:1548–1555.PubMedCrossRef

32.

Wang L, Stewart DB. Increasing hospital costs for Clostridium difficile colitis: type of hospital matters. Surgery. 2011;150:727–735.PubMedCrossRef

33.

Yam FK, Smith KM. “Collateral damage”: antibiotics and the risk of Clostridium difficile infection. Orthopedics. 2005;28:275–279.PubMed

34.

Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT. The burden of Clostridium difficile in surgical patients in the United States. Surg Infect. 2007;8:557–566.CrossRef

Title: Clostridium difficile Colitis in Patients Undergoing Lower-extremity Arthroplasty: Rare Infection With Major Impact
Authors: Mitchell Gil Maltenfort, PhD
Mohammad R. Rasouli, MD
Todd A. Morrison, BS
Javad Parvizi, MD, FRCS
Publication date: 01-10-2013
Publisher: Springer US
Published in: Clinical Orthopaedics and Related Research® / Issue 10/2013
Print ISSN: 0009-921X
Electronic ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-013-2906-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Clostridium difficile Colitis in Patients Undergoing Lower-extremity Arthroplasty: Rare Infection With Major Impact

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Questions/purposes

Methods

Results

Conclusions

Level of Evidence

Please log in to get access to this content

Other articles of this Issue 10/2013

CORR Insights®: Restoration of the Hip Center During THA Performed for Protrusio Acetabuli Is Associated With Better Implant Survival

CORR Insights®: Incidence and Risk Factors for Pulmonary Embolism After Primary Musculoskeletal Tumor Surgery

Does Proximal Rectus Femoris Release Influence Kinematics In Patients With Cerebral Palsy and Stiff Knee Gait?

Restoration of the Hip Center During THA Performed for Protrusio Acetabuli Is Associated With Better Implant Survival

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

CORR Insights®: Outcome of One-stage Cementless Exchange for Acute Postoperative Periprosthetic Hip Infection